Post-injury treatment with 7,8-dihydroxyflavone attenuates white matter pathology in aged mice following focal traumatic brain injury

Traumatic brain injury (TBI) is a major cause of morbidity and mortality, not least in the elderly. The incidence of aged TBI patients has increased dramatically during the last decades. High age is a highly negative prognostic factor in TBI, and pharmacological treatment options are lacking. We use...

Full description

Saved in:
Bibliographic Details
Main Authors: Georgios Michalettos, Fredrik Clausen, Elham Rostami, Niklas Marklund
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Neurotherapeutics
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1878747924001594
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832575454444257280
author Georgios Michalettos
Fredrik Clausen
Elham Rostami
Niklas Marklund
author_facet Georgios Michalettos
Fredrik Clausen
Elham Rostami
Niklas Marklund
author_sort Georgios Michalettos
collection DOAJ
description Traumatic brain injury (TBI) is a major cause of morbidity and mortality, not least in the elderly. The incidence of aged TBI patients has increased dramatically during the last decades. High age is a highly negative prognostic factor in TBI, and pharmacological treatment options are lacking. We used the controlled cortical impact (CCI) TBI model in 23-month-old male and female mice and analyzed the effect of post-injury treatment with 7,8 dihydroxyflavone (7,8-DHF), a brain-derived neurotrophic factor (BDNF)-mimetic compound, on white matter pathology. Following CCI or sham injury, mice received subcutaneous 7,8-DHF injections (5 ​mg/kg) 30 ​min post-injury and were sacrificed on 2, 7 or 14 days post-injury (dpi) for histological and immunofluorescence analyses. Histological assessment with Luxol Fast Blue (LFB)/Cresyl Violet stain showed that administration of 7,8-DHF resulted in preserved white matter tissue at 2 and 7 dpi with no difference in cortical tissue loss at all investigated time points. Treatment with 7,8-DHF led to reduced axonal swellings at 2 and 7 dpi, as visualized by SMI-31 (Neurofilament Heavy Chain) immunofluorescence, and reduced number of TUNEL (Terminal deoxynucleotidyl transferase dUTP nick end labelling)/CC1-positive mature oligodendrocytes at 2 dpi in the perilesional white matter. Post-injury proliferation of Platelet-derived Growth Factor Receptor (PDGFRα)-positive oligodendodrocyte progenitor cells was not altered by 7,8-DHF. Our results suggest that 7,8-DHF can attenuate white matter pathology by mitigating axonal injury and oligodendrocyte death in the aged mouse brain following TBI. These data argue that further exploration of 7,8-DHF towards clinical use is warranted.
format Article
id doaj-art-5efed48d983543b29ae85590b5a52027
institution Kabale University
issn 1878-7479
language English
publishDate 2025-01-01
publisher Elsevier
record_format Article
series Neurotherapeutics
spelling doaj-art-5efed48d983543b29ae85590b5a520272025-02-01T04:11:51ZengElsevierNeurotherapeutics1878-74792025-01-01221e00472Post-injury treatment with 7,8-dihydroxyflavone attenuates white matter pathology in aged mice following focal traumatic brain injuryGeorgios Michalettos0Fredrik Clausen1Elham Rostami2Niklas Marklund3Department of Clinical Sciences Lund, Neurosurgery, Lund University, Lund, SwedenDepartment of Medical Sciences, Section of Neurosurgery, Uppsala University, Uppsala, SwedenDepartment of Medical Sciences, Section of Neurosurgery, Uppsala University, Uppsala, Sweden; Department of Neuroscience, Karolinska Institute, Stockholm, SwedenDepartment of Clinical Sciences Lund, Neurosurgery, Lund University and Lund University Hospital, Lund, Sweden; Corresponding author.Traumatic brain injury (TBI) is a major cause of morbidity and mortality, not least in the elderly. The incidence of aged TBI patients has increased dramatically during the last decades. High age is a highly negative prognostic factor in TBI, and pharmacological treatment options are lacking. We used the controlled cortical impact (CCI) TBI model in 23-month-old male and female mice and analyzed the effect of post-injury treatment with 7,8 dihydroxyflavone (7,8-DHF), a brain-derived neurotrophic factor (BDNF)-mimetic compound, on white matter pathology. Following CCI or sham injury, mice received subcutaneous 7,8-DHF injections (5 ​mg/kg) 30 ​min post-injury and were sacrificed on 2, 7 or 14 days post-injury (dpi) for histological and immunofluorescence analyses. Histological assessment with Luxol Fast Blue (LFB)/Cresyl Violet stain showed that administration of 7,8-DHF resulted in preserved white matter tissue at 2 and 7 dpi with no difference in cortical tissue loss at all investigated time points. Treatment with 7,8-DHF led to reduced axonal swellings at 2 and 7 dpi, as visualized by SMI-31 (Neurofilament Heavy Chain) immunofluorescence, and reduced number of TUNEL (Terminal deoxynucleotidyl transferase dUTP nick end labelling)/CC1-positive mature oligodendrocytes at 2 dpi in the perilesional white matter. Post-injury proliferation of Platelet-derived Growth Factor Receptor (PDGFRα)-positive oligodendodrocyte progenitor cells was not altered by 7,8-DHF. Our results suggest that 7,8-DHF can attenuate white matter pathology by mitigating axonal injury and oligodendrocyte death in the aged mouse brain following TBI. These data argue that further exploration of 7,8-DHF towards clinical use is warranted.http://www.sciencedirect.com/science/article/pii/S1878747924001594Traumatic brain injuryHigh age7,8-DHFWhite matterOligodendrogliaAxonal injury
spellingShingle Georgios Michalettos
Fredrik Clausen
Elham Rostami
Niklas Marklund
Post-injury treatment with 7,8-dihydroxyflavone attenuates white matter pathology in aged mice following focal traumatic brain injury
Neurotherapeutics
Traumatic brain injury
High age
7,8-DHF
White matter
Oligodendroglia
Axonal injury
title Post-injury treatment with 7,8-dihydroxyflavone attenuates white matter pathology in aged mice following focal traumatic brain injury
title_full Post-injury treatment with 7,8-dihydroxyflavone attenuates white matter pathology in aged mice following focal traumatic brain injury
title_fullStr Post-injury treatment with 7,8-dihydroxyflavone attenuates white matter pathology in aged mice following focal traumatic brain injury
title_full_unstemmed Post-injury treatment with 7,8-dihydroxyflavone attenuates white matter pathology in aged mice following focal traumatic brain injury
title_short Post-injury treatment with 7,8-dihydroxyflavone attenuates white matter pathology in aged mice following focal traumatic brain injury
title_sort post injury treatment with 7 8 dihydroxyflavone attenuates white matter pathology in aged mice following focal traumatic brain injury
topic Traumatic brain injury
High age
7,8-DHF
White matter
Oligodendroglia
Axonal injury
url http://www.sciencedirect.com/science/article/pii/S1878747924001594
work_keys_str_mv AT georgiosmichalettos postinjurytreatmentwith78dihydroxyflavoneattenuateswhitematterpathologyinagedmicefollowingfocaltraumaticbraininjury
AT fredrikclausen postinjurytreatmentwith78dihydroxyflavoneattenuateswhitematterpathologyinagedmicefollowingfocaltraumaticbraininjury
AT elhamrostami postinjurytreatmentwith78dihydroxyflavoneattenuateswhitematterpathologyinagedmicefollowingfocaltraumaticbraininjury
AT niklasmarklund postinjurytreatmentwith78dihydroxyflavoneattenuateswhitematterpathologyinagedmicefollowingfocaltraumaticbraininjury